INVO Bioscience (NASDAQ:INVO) Shares Up 3.2% – Here’s Why

Shares of INVO Bioscience, Inc. (NASDAQ:INVO) shot up 3.2% on Thursday . The company traded as high as $0.84 and last traded at $0.81. 25,352 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 1,587,563 shares. The stock had previously closed at $0.79.

INVO Bioscience Stock Up 3.2 %

The firm has a 50 day moving average price of $0.84 and a 200-day moving average price of $0.82.

Institutional Trading of INVO Bioscience

An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. bought a new stake in shares of INVO Bioscience, Inc. (NASDAQ:INVO) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned 2.64% of INVO Bioscience at the end of the most recent reporting period. Institutional investors and hedge funds own 12.02% of the company’s stock.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.